Publicaciones en las que colabora con José Luis Martín Ventura (15)

2023

  1. Protection of diabetes in aortic abdominal aneurysm: Are antidiabetics the real effectors?

    Frontiers in Cardiovascular Medicine, Vol. 10

2022

  1. Annexins and cardiovascular diseases: Beyond membrane trafficking and repair

    Frontiers in Cell and Developmental Biology, Vol. 10

  2. Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm

    Science Advances, Vol. 8, Núm. 11

  3. Rewiring Vascular Metabolism Prevents Sudden Death due to Aortic Ruptures-Brief Report

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 42, Núm. 4, pp. 462-469

2021

  1. Anexinas: implicación en la homeostasis del colesterol, la respuesta inflamatoria y la aterosclerosis

    Clínica e investigación en arteriosclerosis, Vol. 33, Núm. 4, pp. 206-216

  2. Extracellular Tuning of Mitochondrial Respiration Leads to Aortic Aneurysm

    Circulation, Vol. 143, Núm. 21, pp. 2091-2109

  3. Mcp-1 predicts recurrent cardiovascular events in patients with persistent inflammation

    Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-13

2020

  1. CD163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice

    FASEB Journal, Vol. 34, Núm. 11, pp. 14960-14976

  2. Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges

    Cells, Vol. 9, Núm. 2

2019

  1. A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis

    EBioMedicine, Vol. 46, pp. 274-289

  2. Fisiopatología del aneurisma de aorta abdominal: biomarcadores y nuevas dianas terapéuticas

    Clínica e investigación en arteriosclerosis, Vol. 31, Núm. 4, pp. 166-177

2018

  1. Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease

    Atherosclerosis, Vol. 270, pp. 13-20

2017

  1. Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease

    Atherosclerosis, Vol. 260, pp. 130-137

  2. TWEAK blockade decreases atherosclerotic lesion size and progression through suppression of STAT1 signaling in diabetic mice

    Scientific Reports, Vol. 7

2014

  1. Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis

    Journal of the American Heart Association, Vol. 3, Núm. 4